A girl physician or nurse vaccinating a affected person with a syringe.
The EU’s drug regulator stated Tuesday it’s nonetheless deciding whether or not the AstraZeneca Covid-19 vaccine causes blood clots, after a high official stated there was a transparent hyperlink.
The European Medicines Company’s security committee “has not but reached a conclusion and the evaluation is at present ongoing”, the Amsterdam-based EMA stated in a press release to AFP.
“We’ll talk and maintain a press briefing as quickly because the evaluation is finalised. That is at present anticipated tomorrow (Wednesday, 7 April) or on Thursday, 8 April,” it added.
The assertion got here after the EMA’s head of vaccine technique Marco Cavaleri was quoted in Italian media as saying that there was a “clear” connection and that the company would announce it inside hours.
“For my part, we are able to say it now, it’s clear there’s a hyperlink with the vaccine. However we nonetheless have no idea what causes this response,” Cavaleri advised Italy’s Il Messaggero newspaper in an interview.
After a number of nations suspended using the AstraZeneca jab, the EMA stated on 18 March that the advantages of utilizing it outweigh the dangers and it ought to stay in use.
However it has stated there’s a attainable hyperlink to uncommon blood clots and that it could problem up to date recommendation throughout this week’s assembly of its security committee.
In the meantime the World Well being Organisation says the risk-benefit stability for the AstraZeneca Covid-19 vaccine is “nonetheless largely optimistic”.
“There is not any proof that the benefit-risk evaluation for the vaccine must be modified,” Rogerio Pinto de Sa Gaspar, the WHO’s director for regulation and pre-qualification, advised a press convention.